The intraductal component of breast cancer is poorly responsive to neo-adjuvant chemotherapy. [electronic resource]
Producer: 20030320Description: 1027-31 p. digitalISSN:- 1021-335X
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Apoptosis
- Breast Neoplasms -- drug therapy
- Carcinoma, Intraductal, Noninfiltrating -- drug therapy
- Cell Division
- Chemotherapy, Adjuvant
- Cyclophosphamide -- administration & dosage
- Docetaxel
- Doxorubicin -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Humans
- Immunohistochemistry
- In Situ Nick-End Labeling
- Ki-67 Antigen -- biosynthesis
- Middle Aged
- Paclitaxel -- administration & dosage
- Taxoids
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.